Focus Partners Wealth
HAE icon

Focus Partners Wealth’s Haemonetics HAE Stock Holding History

Focus Partners Wealth’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Sell
4,516
-227
-5% -$14.6K ﹤0.01% 2196
2026
Q1 		$267K Sell
4,743
-246
-5% -$16K ﹤0.01% 2259
2025
Q4 		$400K Buy
+4,989
New +$335K ﹤0.01% 2054

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth's HAE Position: Q2 2026 in Review

Focus Partners Wealth reduced its Haemonetics (HAE) stake by 4.8% in Q2 2026, selling an estimated $14.6K and leaving 4,516 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2196.

Focus Partners Wealth first reported a position in HAE in Q4 2025 and has held it in 3 quarters since. The position peaked at $400K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Focus Partners Wealth held 4,516 shares of Haemonetics worth $339K as of Q2 2026.
  • Focus Partners Wealth sold 227 Haemonetics shares in Q2 2026, an estimated $14.6K.
  • Haemonetics made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2196 holding.
  • Focus Partners Wealth first reported a position in Haemonetics in Q4 2025 and has held it in 3 quarters since.
  • Focus Partners Wealth's Haemonetics position peaked at $400K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.